Nano Holdings, Inc. (TYO:4571)
103.00
0.00 (0.00%)
Aug 27, 2026, 11:30 AM JST
Nano Holdings Revenue
Nano Holdings had revenue of 35.00M JPY in the quarter ending June 30, 2026, with 400.00% growth. This brings the company's revenue in the last twelve months to 202.00M, up 75.65% year-over-year. In the fiscal year ending March 31, 2026, Nano Holdings had annual revenue of 174.00M with 61.11% growth.
Revenue (ttm)
202.00M
Revenue Growth
+75.65%
P/S Ratio
45.58
Revenue / Employee
8.78M
Employees
23
Market Cap
9.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 174.00M | 66.00M | 61.11% |
| Mar 31, 2025 | 108.00M | -27.00M | -20.00% |
| Mar 31, 2024 | 135.00M | -67.00M | -33.17% |
| Mar 31, 2023 | 202.00M | 84.18M | 71.45% |
| Mar 31, 2010 | 117.82M | -235.83M | -66.68% |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.14B |
| StemCell Institute | 2.81B |
| Immuno-Biological Laboratories | 1.08B |
| MEDINET | 998.00M |
| OncoTherapy Science | 777.00M |
| Carna Biosciences | 729.00M |
| SUSMED,Inc. | 497.00M |
| CellSeed | 161.00M |